• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病患者冠状动脉扩张起始于发病第几天?

On What Day of Illness Does the Dilatation of Coronary Arteries in Patients With Kawasaki Disease Begin?

机构信息

Department of Pediatrics, NTT Sapporo Medical Center.

出版信息

Circ J. 2017 Dec 25;82(1):247-250. doi: 10.1253/circj.CJ-17-0046. Epub 2017 Aug 25.

DOI:10.1253/circj.CJ-17-0046
PMID:28845030
Abstract

BACKGROUND

In the present study we used echocardiography to investigate coronary artery diameter at the time of diagnosis of Kawasaki disease (KD), before the start of treatment.Methods and Results:Diameters of the right, left main, left anterior descending, and left circumflex coronary arteries were determined in 410 patients before KD treatment commenced. The maximum Z-score was considered to be the pretreatment, maximum coronary artery Z-score (preZmax). The cumulative probability of coronary arterial dilatation was analyzed using the Kaplan-Meier method. In the present study, 31 patients (7.6%) had a preZmax ≥3.0, 56 (13.7%) had a preZmax ≥2.5, and 96 (23.4%) had a preZmax ≥2.0. The cumulative probability of a preZmax ≥2.0 was >20% on Day 5 of illness, 40% on Day 7, and 70% on Day 10. The positive predictive value (PPV) of a preZmax of 2.0 was approximately 0.9 on Day 5 of illness.

CONCLUSIONS

The present study demonstrates that the coronary arteries may dilate before Day 5 of illness, and that the rate of dilatation increases gradually until Day 10. Because preZmax 2.0 has high PPV after Day 5 of illness, it is a useful marker of coronary artery dilatation in the early phase of KD.

摘要

背景

在本研究中,我们使用超声心动图在川崎病(KD)诊断时,即在开始治疗之前,来研究冠状动脉的直径。

方法和结果

在 KD 治疗开始前,我们对 410 例患者的右冠状动脉、左主干、左前降支和左旋支的直径进行了测定。最大 Z 评分被认为是预处理的最大冠状动脉 Z 评分(preZmax)。采用 Kaplan-Meier 方法分析冠状动脉扩张的累积概率。在本研究中,31 例(7.6%)患者的 preZmax≥3.0,56 例(13.7%)患者的 preZmax≥2.5,96 例(23.4%)患者的 preZmax≥2.0。在发病第 5 天,preZmax≥2.0 的累积概率>20%,第 7 天为 40%,第 10 天为 70%。在发病第 5 天,preZmax 为 2.0 的阳性预测值(PPV)约为 0.9。

结论

本研究表明,冠状动脉可能在发病第 5 天之前扩张,扩张速度逐渐增加,直至第 10 天。由于发病后第 5 天的 preZmax 2.0 具有较高的 PPV,因此它是 KD 早期冠状动脉扩张的有用标志物。

相似文献

1
On What Day of Illness Does the Dilatation of Coronary Arteries in Patients With Kawasaki Disease Begin?川崎病患者冠状动脉扩张起始于发病第几天?
Circ J. 2017 Dec 25;82(1):247-250. doi: 10.1253/circj.CJ-17-0046. Epub 2017 Aug 25.
2
Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease.川崎病患者初始冠状动脉正常与随访超声心动图正常的相关性。
JAMA Pediatr. 2018 Dec 1;172(12):e183310. doi: 10.1001/jamapediatrics.2018.3310. Epub 2018 Dec 3.
3
Implications of Changing Z-Score Models for Coronary Artery Dimensions in Kawasaki Disease.川崎病冠状动脉形态改变的 Z 评分模型的意义。
Pediatr Cardiol. 2021 Feb;42(2):432-441. doi: 10.1007/s00246-020-02501-0. Epub 2021 Jan 4.
4
Coronary artery dilation in acute Kawasaki disease and acute illnesses associated with Fever.川崎病急性期冠状动脉扩张和与发热相关的急性疾病。
Pediatr Infect Dis J. 2012 Sep;31(9):924-6. doi: 10.1097/INF.0b013e31826252b3.
5
Changes in Coronary Aneurysm Diameters After Acute Kawasaki Disease from Infancy to Adolescence.婴幼儿时期川崎病后冠状动脉瘤直径的变化。
Pediatr Cardiol. 2021 Dec;42(8):1749-1756. doi: 10.1007/s00246-021-02659-1. Epub 2021 Jun 16.
6
Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.川崎病患儿冠状动脉进行性扩张的危险因素及影响
BMC Pediatr. 2017 Jun 6;17(1):139. doi: 10.1186/s12887-017-0895-8.
7
Progressive Coronary Dilatation Predicts Worse Outcome in Kawasaki Disease.冠状动脉进行性扩张预示川崎病的预后更差。
J Pediatr. 2016 Apr;171:78-82.e1. doi: 10.1016/j.jpeds.2015.12.076. Epub 2016 Feb 4.
8
Coronary artery dimensions may be misclassified as normal in Kawasaki disease.在川崎病中,冠状动脉尺寸可能被误分类为正常。
J Pediatr. 1998 Aug;133(2):254-8. doi: 10.1016/s0022-3476(98)70229-x.
9
[Predicting value of thrombospondin-2 for coronary artery dilatation in patients with Kawasaki disease].[血小板反应蛋白-2对川崎病患者冠状动脉扩张的预测价值]
Zhonghua Er Ke Za Zhi. 2016 Apr;54(4):259-63. doi: 10.3760/cma.j.issn.0578-1310.2016.04.006.
10
Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.川崎病后冠状动脉瘤的中期并发症:来自国际川崎病注册研究。
J Am Heart Assoc. 2020 Aug 4;9(15):e016440. doi: 10.1161/JAHA.119.016440. Epub 2020 Jul 28.

引用本文的文献

1
Heterogeneity in Kawasaki disease patients with coronary artery abnormalities investigated by data-driven cluster analysis.通过数据驱动的聚类分析研究川崎病合并冠状动脉异常患者的异质性。
Pediatr Res. 2025 Jun 20. doi: 10.1038/s41390-025-04205-8.
2
Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment.重症川崎病冠状动脉异常及对免疫球蛋白加环孢素A治疗耐药的危险因素:KAICA试验的亚组分析,环孢素A作为一线治疗的随机试验
Front Pediatr. 2023 Dec 15;11:1321533. doi: 10.3389/fped.2023.1321533. eCollection 2023.
3
Development of a prediction model for progression of coronary artery lesions in Kawasaki disease.
川崎病冠状动脉病变进展预测模型的开发
Pediatr Res. 2024 Mar;95(4):1041-1050. doi: 10.1038/s41390-023-02931-5. Epub 2023 Dec 1.
4
Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease.中性粒细胞减少与川崎病患者的预后无关。
Front Pediatr. 2021 Jun 4;9:652346. doi: 10.3389/fped.2021.652346. eCollection 2021.
5
Value of serial echocardiography in diagnosing Kawasaki's disease.系列超声心动图在诊断川崎病中的价值。
Eur J Pediatr. 2021 Feb;180(2):387-395. doi: 10.1007/s00431-020-03752-y. Epub 2020 Sep 21.